miR-22 inhibits tumor growth and metastasis by targeting ATP citrate lyase: evidence in osteosarcoma, prostate cancer, cervical cancer and lung cancer
Mei Xin(The University of Texas Southwestern Medical Center), Gang Huang(Renji Hospital)
Cited by 173